| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $55.2M | +133.0% |
| Cost of Revenue | $53.5M | +213.6% |
| Gross Profit | $1.7M | -74.0% |
| R&D Expense | $18.8M | +64.4% |
| SG&A Expense | $37.7M | +88.5% |
| Operating Income | -$102.6M | -89.7% |
| Interest Expense | $712K | -88.3% |
| Pre-tax Income | -$86.4M | -695.8% |
| Income Tax | $0 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $229.8M | -25.3% |
| Accounts Receivable | $31.9M | +392.8% |
| Inventory | $10.3M | +99.6% |
| Current Assets | $292.6M | -12.3% |
| Total Assets | $348.1M | -4.1% |
| Current Liabilities | $59.1M | +142.6% |
| Long-term Debt | $29.7M | +196.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.7M | -7.3% |
| Investing Cash Flow | -$23.9M | -404.0% |
| Financing Cash Flow | $20.5M | -94.6% |
| — |
| Net Income | -$86.4M | -695.8% |
| EPS (Basic) | -$0.60 | -300.0% |
| EPS (Diluted) | -$0.60 | -300.0% |
| Total Liabilities |
| $121.1M |
| +67.7% |
| Stockholders' Equity | $227.0M | -22.0% |